Assignee
CANGET BIOTEKPHARMA LLC
US·3 granted patents·1 pending application·1 citations·filing 2019–2024
Top patents by PatentIndex Score
4 records- 0179US11084828B2Use of the FL118 core chemical structure platform to generate FL118 derivatives for treatment of human diseaseCANGET BIOTEKPHARMA LLC·Filed 2019·Granted Aug 10, 2021·1 cites·12 claims
- 0264US2025092058A1Matter of composition, synthesis, formulation and application of fl 118 platform positions 7 and 9-derived analogues for treatment of human diseaseCANGET BIOTEKPHARMA LLC·Filed 2024·Application pending·0 cites
- 0349US12187735B2Matter of composition, synthesis, formulation and application of FL118 platform positions 7 and 9-derived analogues for treatment of human diseaseCANGET BIOTEKPHARMA LLC·Filed 2020·Granted Jan 7, 2025·0 cites·14 claims
- 0444US12268682B2Anticancer drug FL118 formulation for treatment of human cancerCANGET BIOTEKPHARMA LLC·Filed 2020·Granted Apr 8, 2025·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when CANGET BIOTEKPHARMA LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →